Cost-Effectiveness of Screening Asymptomatic Carotid Stenosis by Atherosclerotic Cardiovascular Risk.
Zhu J, Jhang J, Yu H, Mushlin AI, Kamel H, Alemayehu N, Giardina JC, Gupta A, Pandya A.
medRxiv. 2024 May 16. PMID: 38798437
CHDS Core Faculty
Center for Health Decision Science
Harvard T.H. Chan School of Public Health
Concentration Co-Chair, Decision Sciences Concentration for the PhD Program in Health Policy
Health Policy and Management
Harvard T.H. Chan School of Public Health
Dr. Pandya loves teaching introductory health decision science and conducting research built on these methods. His areas of interest are: 1) applied decision science studies evaluating cardiovascular disease policies; 2) connecting cost-effectiveness analysis with broader value-based health policies being implemented or piloted in U.S. health reform; and 3) methodological topics within cost-effectiveness modeling (calibration, validation, distributional cost-effectiveness analysis). His research has been covered in The New York Times, National Public Radio, NBC Nightly News, and other media outlets.
Before joining HPM, Dr. Pandya served as Assistant Professor of Healthcare Policy and Research with a secondary appointment in the Department of Radiology at Weill Cornell Medical College from 2012-2014. He graduated from the Harvard PhD Program in Health Policy in 2012, and holds an MPH from Yale University in Health Policy and Administration (2005) and a BS from Cornell University in Nutritional Sciences (2003). Prior to entering the PhD program, he worked for two years at a health economics/outcomes research consulting firm.
He received the “Outstanding Paper by a Young Investigator Award” from the Society for Medical Decision Making (SMDM) in 2016. He was one of three recipients of the “Teaching Citation Award” from the Harvard T.H. Chan School of Public Health in 2017. He received a “Centre for Health Economics Research Fellowship Award” from the University of York in 2018 (visitation in 2019). He was elected to the SMDM board in 2019 and currently holds the position of Vice President (2023-24). He received the “Roger L. Nichols Excellence in Teaching Award” from the Harvard T.H. Chan School of Public Health in 2022. Dr. Pandya has received grant funding as principal investigator from the National Institutes of Health (R01NS104143, 2018-2023) and the American Heart Association (14CRP18730014, 2014-2015).
Zhu J, Jhang J, Yu H, Mushlin AI, Kamel H, Alemayehu N, Giardina JC, Gupta A, Pandya A.
medRxiv. 2024 May 16. PMID: 38798437
Wechsler PM, Pandya A, Parikh NS, Razzak JA, White H, Navi BB, Kamel H, Liberman AL.
J Am Heart Assoc. 2024 Apr 02. 13(7):e032808. PMID: 38533952
Ito S, Pandya A, Hauser RG, Krishnamurti L, Stites E, Tormey C, Krumholz HM, Hendrickson JE, Goshua G.
Am J Hematol. 2024 04. 99(4):570-576. PMID: 38279581
Choi SE, Pandya A, White J, Mertz E, Normand SL.
JAMA Netw Open. 2024 01 02. 7(1):e2353861. PMID: 38289601
Luviano A, Pandya A.
Circ Cardiovasc Qual Outcomes. 2023 11. 16(11):e010086. PMID: 37920978
Rich KM, Pandya A, Chiosi JJ, Reddy KP, Shebl FM, Ciaranello AL, Neilan AM, Pinkney JA, Losina E, Freedberg KA, Ahonkhai AA, Hyle EP.
JAMA Netw Open. 2023 11 01. 6(11):e2344385. PMID: 38015507
Pei PP, Fitzmaurice KP, Le MH, Panella C, Jones ML, Pandya A, Horsburgh CR, Freedberg KA, Weinstein MC, Paltiel AD, Reddy KP.
MDM Policy Pract. 2023 Jul-Dec. 8(2):23814683231198873. PMID: 37743931
Luviano A, Pandya A, Wright DR.
JAMA Pediatr. 2023 08 01. 177(8):761-763. PMID: 37399039
Potnis KC, Viswanathan G, Bona RD, Ito S, Kempton CL, Pandya A, Krumholz HM, Goshua G.
Am J Hematol. 2023 09. 98(9):E247-E250. PMID: 37401660
Yan BW, Spahillari A, Pandya A.
Circ Cardiovasc Qual Outcomes. 2023 06. 16(6):e009793. PMID: 37278232
Mentoring plays a critical role in how a tight-knit group of health decision science researchers support one another and bring new people into the fold.
Just because a particular health care service is considered not cost effective doesn’t mean it shouldn’t be used, according to a recent article co-authored by Harvard Chan School’s Ankur Pandya.
During the pandemic, Harvard Chan School's Department of Health Policy and Management got creative with virtual programming to keep faculty, staff, and students feeling connected.
Using the coronary artery calcium score to determine when to start statin therapy among African Americans at intermediate risk for atherosclerotic cardiovascular disease is a more cost-effective approach than prescribing the medication to all African American patients at…
A program offering financial incentives to patients and physicians to control cholesterol could be a cost-effective intervention for patients at high risk of cardiovascular disease.